ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Vaccine Therapy Plus QS21 in Treating Patients With Small Cell Lung Cancer That Has Responded to Initial Therapy

This study is ongoing, but not recruiting participants.
Study NCT00004249.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Lung Cancer
2 Additional conditions recognized in this trial
Carcinoma, Small Cell
Lung Neoplasms
3 More general conditions related to this trial
Adenocarcinoma
Carcinoma
Carcinoma, Neuroendocrine
Lung Diseases
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neuroectodermal Tumors
Neuroendocrine Tumors
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
4 Interventions listed in this trial
QS21
keyhole limpet hemocyanin
polysialic acid
5 Additional drug interventions recognized in this trial
Keyhole-limpet hemocyanin
QS 21
6 More general drug interventions related to this trial
Adjuvants, Immunologic
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
7 Sponsors listed in this trial
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers